目次

Table of Content

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Technology
1.1.2. Application
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.2. Approach 1: Commodity flow approach
1.6.3. Volume price analysis (Model 2)
1.6.4. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Technology Outlook
2.2.2. Application Outlook
2.2.3. Regional Outlook
2.3. Competitive Insights

Chapter 3. Transdermal Drug Delivery System Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Increasing Adoption of Transdermal Patches
3.4.1.2. Technological Advancements
3.4.1.3. High Demand for Pain Free Drug Delivery
3.4.2. Market restraint analysis
3.4.2.1. High Cost of Transdermal Technology
3.4.2.2. Limited Number of Approved Medications
3.5. Transdermal Drug Delivery System Market Analysis Tools
3.5.1. Industry Analysis - Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.4. Market Entry Strategies

Chapter 4. Transdermal Drug Delivery System Device: Technology Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Electroporation
4.1.2. Radio Frequency
4.1.3. Iontophoresis
4.1.4. Microporation
4.1.5. Thermal
4.1.6. Mechanical arrays
4.1.7. Ultrasound
4.1.8. Others
4.2. Technology Market Share, 2022& 2030
4.3. Segment Dashboard
4.4. Global Transdermal Drug Delivery System Market by Technology Outlook
4.5. Market Application& Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5.1. Electroporation
4.5.1.1. Market estimates and forecast 2018 - 2030 (Revenue in USD Million)
4.5.2. Radio Frequency
4.5.2.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
4.5.3. Iontophoresis
4.5.3.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
4.5.4. Microporation
4.5.4.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
4.5.5. Thermal
4.5.5.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
4.5.6. Mechanical Arrays
4.5.6.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
4.5.7. Ultrasound
4.5.7.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
4.5.8. Others
4.5.8.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)

Chapter 5. Transdermal Drug Delivery System: Application Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. CNS
5.1.2. Pain Management
5.1.3. Cardiovascular
5.1.4. Hormone
5.1.5. Immunological
5.1.6. Metabolic
5.1.7. Gastrointestinal
5.1.8. Infection
5.1.9. Cancer
5.1.10. Others
5.2. Application Market Share, 2022& 2030
5.3. Segment Dashboard
5.4. Global Transdermal Drug Delivery System Market by Application Outlook
5.5. Market Application& Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5.1. CNS
5.5.1.1. Market estimates and forecast, 2018 - 2030(Revenue in USD Million)
5.5.2. Pain Management
5.5.2.1. Market estimates and forecast, 2018 - 2030(Revenue in USD Million)
5.5.3. Cardiovascular
5.5.3.1. Market estimates and forecast, 2018 - 2030(Revenue in USD Million)
5.5.4. Hormone
5.5.4.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
5.5.5. Immunological
5.5.5.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
5.5.6. Metabolic
5.5.6.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
5.5.7. Gastrointestinal
5.5.7.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
5.5.8. Infection
5.5.8.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
5.5.9. Cancer
5.5.9.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
5.5.10. Others
5.5.10.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
5.5.10.2. Urological
5.5.10.2.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
5.5.10.3. Blood Disorders
5.5.10.3.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
5.5.10.4. Respiratory
5.5.10.4.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
5.5.10.5. Musculoskeletal
5.5.10.5.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)

Chapter 6. Market: Regional Estimates & Trend Analysis
6.1. Regional market share analysis, 2022& 2030
6.2. Regional Market Dashboard
6.3. Global Regional Market Snapshot
6.4. Regional Market Share and Leading Players, 2022
6.4.1. North America
6.4.2. Europe
6.4.3. Asia Pacific
6.4.4. Latin America
6.4.5. Middle East and Africa
6.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
6.5.1. North America
6.5.2. Europe
6.5.3. Asia Pacific
6.5.4. Latin America
6.5.5. Middle East and Africa
6.6. Market Application, & Forecasts and Trend Analysis, 2018 to 2030:
6.7. North America
6.7.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.7.2. U.S.
6.7.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.7.3. Canada
6.7.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.8. Europe
6.8.1. UK
6.8.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.8.2. Germany
6.8.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.8.3. France
6.8.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.8.4. Italy
6.8.4.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.8.5. Spain
6.8.5.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.8.6. Denmark
6.8.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.8.7. Sweden
6.8.7.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.8.8. Norway
6.8.8.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.9. Asia Pacific
6.9.1. Japan
6.9.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.9.2. India
6.9.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.9.3. China
6.9.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.9.4. South Korea
6.9.4.1 Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.9.5. Thailand
6.9.5.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.9.6. Australia
6.9.6.1 Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.10. Latin America
6.10.1. Brazil
6.10.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.10.2. Mexico
6.10.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.10.3. Argentina
6.10.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.11. MEA
6.11.1. South Africa
6.11.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.11.2. Saudi Arabia
6.11.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.11.3. UAE
6.11.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.11.4. Kuwait
6.11.4.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.2.1. Innovators
7.2.2. Market Leaders
7.2.3. Emerging Players
7.3. Vendor Landscape
7.3.1. List of key distributors and channel partners
7.3.2. Key customers
7.3.3. Key company market share analysis, 2022
7.3.4. Novartis AG
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Product benchmarking
7.3.4.4. Strategic initiatives
7.3.5. Johnson & Johnson
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Product benchmarking
7.3.5.4. Strategic initiatives
7.3.6. Mylan Pharmaceuticals, Inc.
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Product benchmarking
7.3.6.4. Strategic initiatives
7.3.7. Boehringer Ingelheim GmbH Overview
7.3.7.1. Financial performance
7.3.7.2. Product benchmarking
7.3.7.3. Strategic initiatives
7.3.8. Biogel Technology, Inc.
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Product benchmarking
7.3.8.4. Strategic initiatives
7.3.9. Transdermal Technologies, Inc.
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. Product benchmarking
7.3.9.4. Strategic initiatives
7.3.10. Skyepharma
7.3.10.1. Company overview
7.3.10.2. Financial performance
7.3.10.3. Product benchmarking
7.3.10.4. Strategic initiatives
7.3.11. Watson Pharmaceuticals, Inc.
7.3.11.1. Company overview
7.3.11.2. Financial performance
7.3.11.3. Product benchmarking
7.3.11.4. Strategic initiatives
7.3.12. 3M Company
7.3.12.1. Company overview
7.3.12.2. Financial performance
7.3.12.3. Product benchmarking
7.3.12.4. Strategic initiatives
7.3.13. Noven Pharmaceuticals, Inc.
7.3.13.1. Company overview
7.3.13.2. Financial performance
7.3.13.3. Product benchmarking
7.3.13.4. Strategic initiatives
7.3.14. 4P Therapeutics, LLC
7.3.14.1. Company overview
7.3.14.2. Financial performance
7.3.14.3. Product benchmarking
7.3.14.4. Strategic initiatives
7.3.15. Transdermal Corporation
7.3.15.1. Company overview
7.3.15.2. Financial performance
7.3.15.3. Product benchmarking
7.3.15.4. Strategic initiatives
7.3.16. Echo Therapeutics, Inc.
7.3.16.1. Company overview
7.3.16.2. Financial performance
7.3.16.3. Product benchmarking
7.3.16.4. Strategic initiatives

List of Tables
Table 1 List of Abbreviation
Table 2 North America transdermal drug delivery system market, by region, 2018 - 2030 (USD Million)
Table 3 North America transdermal drug delivery system market, by Type, 2018 - 2030 (USD Million)
Table 4 North America transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
Table 5 U.S. transdermal drug delivery system market, by Type, 2018 - 2030 (USD Million)
Table 6 U.S. transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
Table 7 Canada transdermal drug delivery system market, by Type, 2018 - 2030 (USD Million)
Table 8 Canada transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
Table 9 Europe transdermal drug delivery system market, by region, 2018 - 2030 (USD Million)
Table 10 Europe transdermal drug delivery system market, by Type, 2018 - 2030 (USD Million)
Table 11 Europe transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
Table 12 Germany transdermal drug delivery system market, by Type, 2018 - 2030 (USD Million)
Table 13 Germany transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
Table 14 UK transdermal drug delivery system market, by Type, 2018 - 2030 (USD Million)
Table 15 UK transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
Table 16 France transdermal drug delivery system market, by Type, 2018 - 2030 (USD Million)
Table 17 France transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
Table 18 Italy transdermal drug delivery system market, by Type, 2018 - 2030 (USD Million)
Table 19 Italy transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
Table 20 Spain transdermal drug delivery system market, by Type, 2018 - 2030 (USD Million)
Table 21 Spain transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
Table 22 Denmark transdermal drug delivery system market, by Type, 2018 - 2030 (USD Million)
Table 23 Denmark transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
Table 24 Sweden transdermal drug delivery system market, by Type, 2018 - 2030 (USD Million)
Table 25 Sweden transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
Table 26 Norway transdermal drug delivery system market, by Type, 2018 - 2030 (USD Million)
Table 27 Norway transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
Table 28 APAC transdermal drug delivery system market, by region, 2018 - 2030 (USD Million)
Table 29 APAC transdermal drug delivery system market, by Type, 2018 - 2030 (USD Million)
Table 30 APAC transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
Table 31 Japan transdermal drug delivery system market, by Type, 2018 - 2030 (USD Million)
Table 32 Japan transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
Table 33 India transdermal drug delivery system market, by Type, 2018 - 2030 (USD Million)
Table 34 India transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
Table 35 China transdermal drug delivery system market, by Type, 2018 - 2030 (USD Million)
Table 36 China transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
Table 37 South Korea transdermal drug delivery system market, by Type, 2018 - 2030 (USD Million)
Table 38 South Korea transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
Table 39 Thailand transdermal drug delivery system market, by Type, 2018 - 2030 (USD Million)
Table 40 Thailand transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
Table 41 Australia transdermal drug delivery system market, by Type, 2018 - 2030 (USD Million)
Table 42 Australia transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
Table 43 Latin America transdermal drug delivery system market, by region, 2018 - 2030 (USD Million)
Table 44 Latin America transdermal drug delivery system market, by Type, 2018 - 2030 (USD Million)
Table 45 Latin America transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
Table 46 Brazil transdermal drug delivery system market, by Type, 2018 - 2030 (USD Million)
Table 47 Brazil transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
Table 48 Mexico transdermal drug delivery system market, by Type, 2018 - 2030 (USD Million)
Table 49 Mexico transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
Table 50 Argentina transdermal drug delivery system market, by Type, 2018 - 2030 (USD Million)
Table 51 Argentina transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
Table 52 Middle East and Africa transdermal drug delivery system market, by region, 2018 - 2030 (USD Million)
Table 53 Middle East and Africa transdermal drug delivery system market, by Type, 2018 - 2030 (USD Million)
Table 54 Middle East and Africa transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
Table 55 South Africa transdermal drug delivery system market, by Type, 2018 - 2030 (USD Million)
Table 56 South Africa transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
Table 57 Saudi Arabia transdermal drug delivery system market, by Type, 2018 - 2030 (USD Million)
Table 58 Saudi Arabia transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
Table 59 UAE transdermal drug delivery system market, by Type, 2018 - 2030 (USD Million)
Table 60 UAE transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
Table 61 Kuwait transdermal drug delivery system market, by Type, 2018 - 2030 (USD Million)
Table 62 Kuwait transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)

List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Transdermal drug delivery system: market outlook
Fig. 14 Transdermal drug delivery system market competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Transdermal drug delivery system market driver impact
Fig. 20 Transdermal drug delivery system market restraint impact
Fig. 21 Transdermal drug delivery system market strategic initiatives analysis
Fig. 22 Transdermal drug delivery system market: Type movement analysis
Fig. 23 Transdermal drug delivery system market: Type outlook and key takeaways
Fig. 24 Transdermal drug delivery market estimates and forecast, 2018 - 2030
Fig. 25 Electroporation estimates and forecast, 2018 - 2030
Fig. 26 Radio frequency market estimates and forecast, 2018 - 2030
Fig. 27 Iontophoresis market estimates and forecast, 2018 - 2030
Fig. 28 Microporation estimates and forecast, 2018 - 2030
Fig. 29 Thermal market estimates and forecast, 2018 - 2030
Fig. 30 Mechanical arrays market estimates and forecast, 2018 - 2030
Fig. 31 Ultrasound market estimates and forecast, 2018 - 2030
Fig. 32 Others market estimates and forecast, 2018 - 2030
Fig. 33 Transdermal drug delivery system market: application movement analysis
Fig. 34 Transdermal drug delivery system market: application outlook and key takeaways
Fig. 35 CNS estimates and forecast, 2018 - 2030
Fig. 36 Pain Management estimates and forecast, 2018 - 2030
Fig. 37 Cardiovascular estimates and forecast, 2018 - 2030
Fig. 38 Hormone estimates and forecast, 2018 - 2030
Fig. 39 Immunological estimates and forecast, 2018 - 2030
Fig. 40 Metabolic estimates and forecast, 2018 - 2030
Fig. 41 Gastrointestinal estimates and forecast, 2018 - 2030
Fig. 42 Infection estimates and forecast, 2018 - 2030
Fig. 43 Cancer estimates and forecast, 2018 - 2030
Fig. 44 Others estimates and forecast, 2018 - 2030
Fig. 45 Global Transdermal drug delivery system market: regional movement analysis
Fig. 46 Global Transdermal drug delivery system market: regional outlook and key takeaways
Fig. 47 Global market share and leading players
Fig. 48 North America market share and leading players
Fig. 49 Europe market share and leading players
Fig. 50 Asia Pacific market share and leading players
Fig. 51 Latin America market share and leading players
Fig. 52 Middle East & Africa market share and leading players
Fig. 53 North America: SWOT
Fig. 54 Europe SWOT
Fig. 55 Asia Pacific SWOT
Fig. 56 Latin America SWOT
Fig. 57 MEA SWOT
Fig. 58 North America, by country
Fig. 59 North America
Fig. 60 North America market estimates and forecast, 2018 - 2030
Fig. 61 U.S.
Fig. 62 U.S. market estimates and forecast, 2018 - 2030
Fig. 63 Canada
Fig. 64 Canada market estimates and forecast, 2018 - 2030
Fig. 65 Europe
Fig. 66 Europe market estimates and forecast, 2018 - 2030
Fig. 67 UK
Fig. 68 UK market estimates and forecast, 2018 - 2030
Fig. 69 Germany
Fig. 70 Germany market estimates and forecast, 2018 - 2030
Fig. 71 France
Fig. 72 France market estimates and forecast, 2018 - 2030
Fig. 73 Italy
Fig. 74 Italy market estimates and forecast, 2018 - 2030
Fig. 75 Spain
Fig. 76 Spain market estimates and forecast, 2018 - 2030
Fig. 77 Denmark
Fig. 78 Denmark market estimates and forecast, 2018 - 2030
Fig. 79 Sweden
Fig. 80 Sweden market estimates and forecast, 2018 - 2030
Fig. 81 Norway
Fig. 82 Norway market estimates and forecast, 2018 - 2030
Fig. 83 Asia Pacific
Fig. 84 Asia Pacific market estimates and forecast, 2018 - 2030
Fig. 85 Japan
Fig. 86 Japan market estimates and forecast, 2018 - 2030
Fig. 87 India
Fig. 88 India market estimates and forecast, 2018 - 2030
Fig. 89 China
Fig. 90 China market estimates and forecast, 2018 - 2030
Fig. 91 South Korea
Fig. 92 South Korea market estimates and forecast, 2018 - 2030
Fig. 93 Thailand
Fig. 94 Thailand market estimates and forecast, 2018 - 2030
Fig. 95 Australia
Fig. 96 Australia market estimates and forecast, 2018 - 2030
Fig. 97 Latin America
Fig. 98 Latin America market estimates and forecast, 2018 - 2030
Fig. 99 Brazil
Fig. 100 Brazil market estimates and forecast, 2018 - 2030
Fig. 101 Mexico
Fig. 102 Mexico market estimates and forecast, 2018 - 2030
Fig. 103 Argentina
Fig. 104 Argentina market estimates and forecast, 2018 - 2030
Fig. 105 Middle East and Africa
Fig. 106 Middle East and Africa market estimates and forecast, 2018 - 2030
Fig. 107 South Africa
Fig. 108 South Africa market estimates and forecast, 2018 - 2030
Fig. 109 Saudi Arabia
Fig. 110 Saudi Arabia market estimates and forecast, 2018 - 2030
Fig. 111 UAE
Fig. 112 UAE market estimates and forecast, 2018 - 2030
Fig. 113 Kuwait
Fig. 114 Kuwait market estimates and forecast, 2018 - 2030
Fig. 115 Participant categorization- Transdermal drug delivery system market
Fig. 116 Market share of key market players- Transdermal drug delivery system